empacyrl10&5mg30tab

Empacyrl 10/5 mg is a combination medication used in the management of type 2 diabetes mellitus. It contains Empagliflozin, an SGLT2 inhibitor that helps the kidneys remove glucose from the bloodstream through urine, and Linagliptin, a DPP-4 inhibitor that increases the levels of incretin hormones to stimulate insulin release and decrease glucose production by the liver. This dual-action approach provides effective glycemic control for patients who require more than one oral agent to maintain target blood sugar levels.